Coherus Oncology, Inc.CHRSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank38
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P38
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-138.51M-577.7%
2024$-20.44M+88.3%
2023$-174.88M+27.5%
2022$-241.12M-544.2%
2021$-37.43M-124.3%
2020$154.15M+443.6%
2019$28.36M+117.8%
2018$-159.27M+20.5%
2017$-200.29M+20.7%
2016$-252.54M-